GlaxoSmithKline: Cellulitis trials

The registry lists 10 Cellulitis studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 1 3Phase 2 1Phase 3 3Phase 4 1No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure InfectionCompletedNCT01209078Phase 2Results posted
• Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSACompletedNCT00852540Phase 3Results posted
• Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL)CompletedNCT00684177Phase 3Results posted
• Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.CompletedNCT00555061Phase 4Results posted
• Bioequivalence Study for an IsotretinoinCompletedNCT01863615Phase 1
• Retapamulin Microdialysis Feasibility StudyCompletedNCT01812382Phase 1
• Bioequivalence Minocycline BioequivalenceCompletedNCT01755611Phase 1
• ALTARGO(Retapamulin) PMS(Post-marketing Surveillance)CompletedNCT01445600
• United States Pharmacovigilence Retapamulin-PrescribingCompletedNCT01153880
• Topical SB-275833 Ointment, 1% For The Treatment Of ImpetigoCompletedNCT00133874Phase 3